These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37093785)

  • 1. Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study.
    Fukudo S; Nakaya K; Muratsubaki T; Nakaya N; Hozawa A; Bangdiwala SI; Palsson OS; Sperber AD; Kanazawa M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14581. PubMed ID: 37093785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study.
    Purssell H; Bennett L; Street O; Hanley KP; Hanley N; Vasant DH; Athwal VS
    Sci Rep; 2023 May; 13(1):8769. PubMed ID: 37253969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
    Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology and impact of disorders of gut-brain interaction in Canada: Results from the Rome Foundation Global Epidemiologic Study.
    Rodrigues DM; Poitras P; Day AG; Sperber AD; Palsson O; Bangdiwala SI; Vanner SJ
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14585. PubMed ID: 36989173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Work productivity and activity impairment in disorders of gut-brain interaction: Data from the Rome Foundation Global Epidemiology Study.
    Frändemark Å; Törnblom H; Hreinsson JP; Andresen V; Benninga MA; Corazziari ES; Fukudo S; Mulak A; Santos J; Sperber AD; Bangdiwala SI; Palsson OS; Simrén M
    United European Gastroenterol J; 2023 Jul; 11(6):503-513. PubMed ID: 37332146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of disorders of gut-brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study.
    Hreinsson JP; Wong RKM; Tack J; Whorwell P; Benninga MA; Andresen V; Bonaz B; Choi SC; Corazziari ES; Santos J; Fukudo S; Kanazawa M; Fang X; Bangdiwala SI; Sperber AD; Palsson OS; Simrén M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14566. PubMed ID: 36961016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology and psychological comorbidity of disorders of gut-brain interaction in Australia: Results from the Rome Foundation Global Epidemiology Study.
    Knowles SR; Apputhurai P; Palsson OS; Bangdiwala S; Sperber AD; Mikocka-Walus A
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14594. PubMed ID: 37052411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study.
    Flores-Arriaga J; Aso MC; Izagirre A; Sperber AD; Palsson OS; Bangdiwala SI; Lanas Á; Bujanda L; Lobo B; Alonso-Cotoner C; Sánchez-Pla Á; Santos J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14582. PubMed ID: 37010843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of disorders of gut-brain interaction in Belgium and differences between two language groups: Results from the Rome foundation global epidemiology study.
    Broeders B; Devolder E; Jones M; Simrén M; Bangdiwala SI; Sperber AD; Palsson OS; Tack J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14588. PubMed ID: 37018388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of disorders of Gut-Brain interaction in Israel: Results from the Rome Foundation global epidemiology study.
    Sperber AD; Freud T; Abu-Freha N; Shibli F; Brun R; Bangdiwala SI; Palsson OS; Dickman R
    Neurogastroenterol Motil; 2022 Aug; 34(8):e14323. PubMed ID: 35072332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aging gastrointestinal tract: Epidemiology and clinical significance of disorders of gut-brain interaction in the older general population.
    Sperber AD; Freud T; Palsson OS; Bangdiwala SI; Simren M
    Aliment Pharmacol Ther; 2024 Aug; 60(4):446-456. PubMed ID: 38837277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome.
    Weerts ZZRM; Vork L; Mujagic Z; Keszthelyi D; Hesselink MAM; Kruimel J; Leue C; Muris JWM; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2019 Aug; 31(8):e13629. PubMed ID: 31119844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide population prevalence and impact of sub-diagnostic gastrointestinal symptoms.
    Palsson OS; Tack J; Drossman DA; Le Nevé B; Quinquis L; Hassouna R; Ruddy J; Morris CB; Sperber AD; Bangdiwala SI; Simrén M
    Aliment Pharmacol Ther; 2024 Apr; 59(7):852-864. PubMed ID: 38311841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and impact of disorders of Gut-Brain interaction in Sweden.
    Tornkvist NT; Simrén M; Hreinsson JP; Tack J; Bangdiwala SI; Sperber AD; Palsson OS; Josefsson A; Törnblom H
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14578. PubMed ID: 37018426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global prevalence and burden of meal-related abdominal pain.
    Colomier E; Melchior C; Algera JP; Hreinsson JP; Störsrud S; Törnblom H; Van Oudenhove L; Palsson OS; Bangdiwala SI; Sperber AD; Tack J; Simrén M
    BMC Med; 2022 Feb; 20(1):71. PubMed ID: 35172840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the epidemiology of disorders of gut-brain interaction in four Latin American countries: Results of The Rome Foundation Global Epidemiology Study.
    Schmulson MJ; Puentes-Leal GA; Bustos-Fernández L; Francisconi C; Hani A; López-Colombo A; Palsson OS; Bangdiwala SI; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14569. PubMed ID: 36989176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study.
    Jaafari H; Houghton LA; West RM; Agrawal A; Aziz I; Black CJ; Corsetti M; Shuweihdi F; Eugenicos M; Paine PA; Ford AC; Whorwell PJ; Bangdiwala SI; Palsson OS; Sperber AD; Vasant DH
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14574. PubMed ID: 37018424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.